Please select the option that best describes you:
Would you ever consider stopping immunotherapy in a patient with metastatic melanoma after achieving a good response?
Would your recommendations change if it was a partial vs complete radiographic response?
Answer from: Medical Oncologist at Academic Institution
Yes, I would consider stopping immunotherapy in a patient with metastatic melanoma after achieving a good response.Data of 655 melanoma patients treated in pembrolizumab phase 1 KEYNOTE-001 study has shown 95 patients (14.5%) achieved CR after a median follow-up of 32 months. Treatment was discontin...
Sign in or Register to read more